Baseline microbiota activity and influence responses to prebiotic initial bifidobacteria counts dosing in healthy subjects

被引:93
作者
De Preter, V. [1 ]
Vanhoutte, T. [2 ]
Huys, G. [2 ]
Swings, J.
Rutgeerts, P. [1 ]
Verbeke, K. [1 ]
机构
[1] Katholieke Univ Leuven Hosp, Dept Gastroenterol Res, B-3000 Louvain, Belgium
[2] Univ Ghent, Microbiol Lab, Ghent, Belgium
关键词
D O I
10.1111/j.1365-2036.2007.03588.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Dietary intervention with prebiotics can cause changes in the colonic microbiota and their metabolic activities. Aim To investigate whether the response to prebiotic dosing is influenced by the baseline metabolic activity of the colonic flora and bifidobacteria counts. Methods The 4-week effect of lactulose (10 g bid.; n = 29) and oligofructose-enriched inulin (10 9 bid.; n = 19) was evaluated in healthy human volunteers. Lactose-[N-15, N-15]-ureide was used to study the colonic NH3-metabolism. Urine (48 h) and faeces (72 h) were collected and analysed for p-cresol and N-15-content by gas chromatography-mass spectrometry and isotope ratio mass spectrometer, respectively. Faecal bifidobacteria were quantified by real-time polymerase chain reaction. Results After the 4-week prebiotic administration period, the urinary excretion of p-cresol and N-15 was significantly decreased in both groups (P < 0.05) corresponding to a significantly higher faecal excretion of N-15 (P < 0.05). The decrease in urinary 15 N and p-cresol excretion significantly correlated with baseline 15 N and p-cresol levels (P < 0.05), indicating that subjects with higher baseline levels showed a higher response to prebiotic dosing. Furthermore, a significant correlation was seen between baseline bifidobacteria counts and the effect of prebiotic intake (P < 0.05). Conclusion The response to prebiotic dosing, as indicated by the fate of NH3, p-creSol and bifidobacteria, is determined by the initial colonic conditions.
引用
收藏
页码:504 / 513
页数:10
相关论文
共 46 条
[1]
Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients [J].
Bammens, B ;
Evenepoel, P ;
Keuleers, H ;
Verbeke, K ;
Vanrenterghem, Y .
KIDNEY INTERNATIONAL, 2006, 69 (06) :1081-1087
[2]
Resistant starch lowers fecal concentrations of ammonia and phenols in humans [J].
Birkett, A ;
Muir, J ;
Phillips, J ;
Jones, G ;
ODea, K .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1996, 63 (05) :766-772
[3]
PRODUCTION OF URINARY PHENOLS BY GUT BACTERIA AND THEIR POSSIBLE ROLE IN CAUSATION OF LARGE BOWEL CANCER [J].
BONE, E ;
TAMM, A ;
HILL, M .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1976, 29 (12) :1448-1454
[4]
The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans:: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study [J].
Bouhnik, Y ;
Raskine, L ;
Simoneau, G ;
Vicaut, E ;
Neut, C ;
Flourié, B ;
Brouns, F ;
Bornet, FR .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2004, 80 (06) :1658-1664
[5]
Lactulose ingestion increases faecal bifidobacterial counts:: A randomised double-blind study in healthy humans [J].
Bouhnik, Y ;
Attar, A ;
Joly, FA ;
Riottot, M ;
Dyard, F ;
Flourié, B .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2004, 58 (03) :462-466
[6]
Collins MD, 1999, AM J CLIN NUTR, V69, p1052S, DOI 10.1093/ajcn/69.5.1052s
[7]
Digestion and physiological properties of resistant starch in the human large bowel [J].
Cummings, JH ;
Beatty, ER ;
Kingman, SM ;
Bingham, SA ;
Englyst, HN .
BRITISH JOURNAL OF NUTRITION, 1996, 75 (05) :733-747
[8]
Cummings JH, 2001, AM J CLIN NUTR, V73, p415S, DOI 10.1093/ajcn/73.2.415s
[9]
EFFECT OF MEAT PROTEIN AND DIETARY FIBER ON COLONIC FUNCTION AND METABOLISM .2. BACTERIAL METABOLITES IN FECES AND URINE [J].
CUMMINGS, JH ;
HILL, MJ ;
BONE, ES ;
BRANCH, WJ ;
JENKINS, DJA .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1979, 32 (10) :2094-2101
[10]
Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uremic and normal serum [J].
de Loor, H ;
Bammens, B ;
Evenepoel, P ;
De Preter, V ;
Verbeke, K .
CLINICAL CHEMISTRY, 2005, 51 (08) :1535-1538